Found 4 Enz. Inhib. hit(s) with Target = 'Leucyl-cystinyl aminopeptidase' and Ligand = 'BDBM271210' TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.
US Patent
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.70nMAssay Description:IRAP: Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP....More data for this Ligand-Target Pair
TargetLeucyl-cystinyl aminopeptidase(Rattus norvegicus)
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.70nMAssay Description:Rat epididymal fat pads were homogenized and subjected to ultracentrifugation at 100,000×g for 30 minutes to obtain microsomes containing IRAP. The m...More data for this Ligand-Target Pair
